Welcome to our dedicated page for 3D Systems news (Ticker: DDD), a resource for investors and traders seeking the latest updates and insights on 3D Systems stock.
3D Systems Corporation develops additive manufacturing and digital manufacturing solutions built around 3D printers, materials, software and application engineering services. Its news commonly covers production systems for polymers and metals, NextDent dental printing and materials, SLA technology, factory software such as AddiTrak, and customer deployments in medical, dental, aerospace, defense, transportation, motorsports and industrial markets.
Company updates also include financial results, cost and efficiency programs, leadership changes, regulatory certifications for dental products, and commercial adoption of healthcare and industrial applications. These developments reflect the company’s focus on full-service solutions that combine hardware, materials, software and manufacturing expertise.
3D Systems (NYSE: DDD) announced that BWT Alpine F1 Team has purchased four SLA 750 3D printing systems to enhance productivity and part quality in its operations. This acquisition allows the team to produce 25,000 parts annually, significantly improving wind tunnel testing models using 3D Systems’ Accura Composite PIV material. The SLA 750 systems were chosen after rigorous testing, demonstrating superior print quality and efficiency. BWT Alpine F1 Team highlighted the systems' ability to reduce build times while maintaining high geometric accuracy and surface quality, ultimately accelerating innovation and design iteration.
3D Systems (NYSE: DDD) has announced the launch of its Regenerative Tissue Program, focusing on developing bioprinted human tissues for various surgical applications. The program leverages the company’s expertise in solid organ development and advanced bioprinting technology. The initial product targets patient-specific regenerative breast tissue (RBT™), addressing the growing need for long-term solutions for breast reconstruction among cancer survivors. With a focus on high-resolution scaffolds and patient-derived cells, 3D Systems aims to improve surgical outcomes and elevate patient experiences. This program builds on over a decade of collaboration with surgeons and extensive research in tissue regeneration.
3D Systems has launched the ProJet MJP 2500W Plus, a cutting-edge 3D printer tailored for the jewelry manufacturing sector, valued at $25 billion. This innovative machine boasts a 2x improvement in vertical resolution and enhances throughput by 25%, allowing for faster production of 100% wax casting patterns. The printer minimizes the need for costly manual polishing, reducing precious metal waste and increasing profitability for users. Designed for high-quality and complex jewelry designs, it supports rapid design iterations and mass customization, aligning with the growing demand in the jewelry additive manufacturing market.
3D Systems (NYSE: DDD) appointed Dr. Rebekah Gee to its Medical Advisory Board, effective March 1, 2023. Dr. Gee, a public health policy expert and former Secretary of the Louisiana Department of Health, brings extensive experience in healthcare innovation and policy implementation. The advisory board, established in May 2022, aims to guide the company's regenerative medicine initiatives, focusing on advanced 3D printing technologies for human organ production and related applications. Dr. Gee's insights will be pivotal for navigating healthcare delivery challenges, including patient insurance and reimbursement issues, supporting 3D Systems' strategic goals in the medical sector.
3D Systems (NYSE:DDD) has announced the release date for its fourth quarter and full year 2022 financial results, scheduled for February 28, 2023. A conference call to discuss these results will take place on March 1, 2023, at 8:30 a.m. Eastern Time. Investors can access the call via telephone or listen to a live webcast on the company's investor relations website. 3D Systems has over 35 years of experience in 3D printing, providing innovative solutions across various industries including healthcare and aerospace. For more details, visit their investor relations page.
3D Systems (NYSE: DDD) has formed a three-year technical partnership with Stewart-Haas Racing, aimed at enhancing the racing team's engineering capabilities. Utilizing 3D Systems' ProX 800 and Figure 4 printers, the partnership will facilitate rapid design and production of crucial components, improving the speed and performance of racecars. This collaboration allows for quicker iteration on designs and prototyping, essential for attaining a competitive edge. The partnership officially commences with the NASCAR Xfinity Series race at Daytona on February 18, 2023.
3D Systems (NYSE:DDD) announced that rms Company, a leading medical device manufacturer, has integrated the DMP Flex 350 Dual into its production process. This addition increases productivity by up to 50%, enhancing rms' powder to package capabilities and expanding the range of implants produced. With over 30 DMP printers, rms is positioned to innovate and streamline the manufacturing of high-quality, tight-tolerance medical devices, particularly titanium implants. The DMP Flex 350 Dual's dual-laser system allows for greater efficiency without compromising precision, aligning with current industry demands.
3D Systems (NYSE:DDD) appointed Mr. Bert Bruce to its Medical Advisory Board to enhance its regenerative medicine initiatives. The board aims to guide efforts in 3D printing vascularized tissues for organ manufacturing and drug development, potentially reducing animal trials. Mr. Bruce, leading the Rare Disease Business Unit at Pfizer, brings over 30 years of pharmaceutical experience. He has a strong background in drug discovery and commercialization. Dr. Jeffrey Graves, CEO, highlighted Bruce's expertise as vital for accelerating the company’s advancements in regenerative medicine and related technologies.
3D Systems (NYSE: DDD) has appointed Dr. Joe Zuiker as Executive Vice President, Engineering and Operations, effective December 12, 2022. Dr. Zuiker brings extensive experience in technical leadership across various industries. Alongside him, Dr. Brent Stucker has been elevated to Chief Technology Officer for Additive Manufacturing. This leadership change aims to bolster 3D Systems' position in the additive manufacturing sector and enhance its product development capabilities as demand for 3D printing increases among customers.
3D Systems (NYSE: DDD) has announced a strategic partnership with Wematter, becoming the exclusive worldwide distributor of the Wematter Gravity Selective Laser Sintering (SLS) solution. This compact, affordable SLS system, designed for diverse applications including medical and automotive industries, occupies less space while delivering a larger build volume. The Gravity allows for easy installation, cloud connectivity, and efficient recycling of materials, offering a cost-effective solution for manufacturers. It will be expanded to the Americas and Asia Pacific by Q2 2023.